The WATCHMAN FLX is the only FDA-approved device for the reduction of stroke risk in patients with non-valvular atrial fibrillation (A Fib).

Qure4u's holistic patient engagement platform and contactless "digital front door" offers patients and providers a scalable, EHR-embedded platform that supports the entire care journey.

ClearMask™ is the world's first FDA-cleared, fully transparent surgical mask that can be used in hospitals, clinics, schools, retail, hospitality, and other settings. The mask is optimized for maximum clarity and comfort

The ‘AMBITION' trial, is designed to assess safety, tolerability, and pharmacokinetics of 75 mg CRV431, administered orally to F2 and F3 NASH patients